Back to search
FDAFDA · Food and drugs·Recall number D-892-2013

buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01

Published August 21, 2013 · Recall initiated: February 4, 2013

Summary

FDA records drug Class III recall D-892-2013, published August 21, 2013 and initiated February 4, 2013. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 389 cartons; Lot: The following codes are affects by the recall: Lot #114500, Exipration Date 08/2013, repackaging date 12/04/2011. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
American Health Packaging
Distributor
Nationwide
Lot
The following codes are affects by the recall: Lot #114500, Exipration Date 08/2013, repackaging date 12/04/2011.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01 recalled?

Yes. FDA published recall D-892-2013 on August 21, 2013. Reported hazard: Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.

What should I do if I have this product?

Voluntary: Firm initiated · Letter